Search

everythinglearnresearchcommunity

for

Search:↓

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Most patients improved with oral contraceptives, but some needed additional treatment.

Goserelin injections can effectively manage hyperandrogenism symptoms in postmenopausal women who can't have surgery.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

Bilateral salpingo-oophorectomy resolved hyperandrogenism in a postmenopausal woman with rare ovarian tumors.

Antiandrogen therapy may be beneficial for women with hidradenitis suppurativa.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

High-dose androgen therapy can help manage certain types of androgen resistance.

Retinoids may improve hair growth in androgenic alopecia when used with other treatments.

The drug combination was safe and showed promise in treating advanced tumors.

MK-5108 is safe and shows potential against tumors, especially alone.

5ARIs like finasteride can help prevent prostate cancer and treat BPH, but guidelines should be updated to reflect this.

5-α-reductase inhibitors don't prevent prostate cancer but may reduce unnecessary biopsies.

Patients with metastatic breast cancer treated with epirubicin and docetaxel had a good response and maintained their quality of life.

Estradiol and castration reduced prostate cancer development in rats when applied at early stages, but were ineffective after cancer was established.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Afatinib often causes skin problems that need proactive management.

Taking 5α-reductase inhibitors does not significantly increase the risk of breast cancer in men.

New drug dutasteride effectively treats hair loss, but use cautiously due to potential sexual side effects.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Dutasteride may help treat prostate cancer by causing cancer cells to shrink and die.

Chemotherapy adds to, but doesn't enhance, the effects of immunotherapy in lung cancer treatment.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.

Cyproterone acetate is a safe treatment that causes modest feminization in transgender female adolescents, and works better with added estrogens.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Hormonal therapy is becoming a promising treatment for acne.